As analysed in a material comprising of all breast cancer subtypes (n = 401), breast carcinomas lacking PTTG1IP immunoexpression and particularly the lack of PTTG1IP expression in combination with high securin expression were associated with an increased risk of breast cancer death. This evidence concerns the gene PTTG1IP and breast cancer.